Generative Artificial Intelligence (AI) In Pharmaceutical Market Anticipated To Witness Robust Growth, Surpassing $7.16 Billion By 2029

The Generative Artificial Intelligence (AI) In Pharmaceutical Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Generative Artificial Intelligence (AI) In Pharmaceutical Market Size and Its Estimated Growth Rate?
The generative AI in pharmaceuticals market size will grow from $1.85 billion in 2024 to $2.43 billion in 2025, with a CAGR of 31.3%. The historic growth is attributed to increases in computational power, the rise of big data in healthcare, more R&D investments, improved data quality and integration, and the expansion of cloud computing.

The generative AI in pharmaceutical market size is expected to reach $7.16 billion in 2029 at a CAGR of 31.0%. Growth is attributed to early disease detection focus, regulatory support, computational power, drug development costs, and data availability. Key trends include blockchain-AI integration, data integration, disease diagnosis improvements, automated drug repurposing, and real-time clini

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19474

How Are Emerging Segments Shaping the Generative Artificial Intelligence (AI) In Pharmaceutical Market Landscape?
The generative artificial intelligence (AI) in pharmaceutical market covered in this report is segmented -

1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies
3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications

Subsegments:
1) By Small Molecule: Drug Discovery And Design, Lead Optimization For Small Molecule Compounds, Predictive Modeling For Pharmacokinetics And Toxicity, Virtual Screening Of Compound Libraries, Personalized Medicine Approaches For Small Molecule Therapies
2) By Large Molecule: Biologics Discovery And Development, Monoclonal Antibody Design, Protein Engineering And Optimization, Vaccine Development And Optimization, Predictive Models For Biopharmaceutical Efficacy And Safety.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19474&type=smp

Which Growth Factors Are Influencing Generative Artificial Intelligence (AI) In Pharmaceutical Market Expansion?
The growing emphasis on personalized medicine is likely to accelerate the development of generative artificial intelligence (AI) in the pharmaceutical market. Personalized medicine adapts treatment to individual genetic and lifestyle profiles, with increased focus driven by advancements in genetic technologies. Generative AI supports this by enabling custom drug development and improved treatment outcomes. For instance, in February 2024, the Personalized Medicine Coalition noted the FDA approved 16 new personalized therapies for rare diseases in 2023, compared to six in 2022. Thus, rising focus on personalized medicine is propelling generative AI in the pharmaceutical market.

Who Are the Dominant Players Across Different Generative Artificial Intelligence (AI) In Pharmaceutical Market Segments?
Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

What Are the Major Trends Shaping the Generative Artificial Intelligence (AI) In Pharmaceutical Market?
Companies in the pharmaceutical market are developing AI healthcare microservices to streamline drug discovery and other medical functions. Nvidia Corporation, in March 2024, introduced generative AI microservices to enhance workflows in drug discovery, offering optimized tools for genomics, medical imaging, and AI-driven healthcare functions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/generative-artificial-intelligence-ai-in-pharmaceutical-global-market-report

Which Geographic Regions Are Expected to Dominate the Generative Artificial Intelligence (AI) In Pharmaceutical Market in the Coming Years?
North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2024. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Generative Artificial Intelligence (AI) In Pharmaceutical Market?
2. What is the CAGR expected in the Generative Artificial Intelligence (AI) In Pharmaceutical Market?
3. What Are the Key Innovations Transforming the Generative Artificial Intelligence (AI) In Pharmaceutical Industry?
4. Which Region Is Leading the Generative Artificial Intelligence (AI) In Pharmaceutical Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.